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In traditional folklore, medicinal herbs play a vital role in the prevention and treatment of microbial diseases. In the present study,
the phenolic profiles of the medicinal plants Asparagus aethiopicus L., Citrullus colocynthis L., Senna alexandrina L., Kalanchoe
delagoensis L., Gasteria pillansii L., Cymbopogon citratus, Brassica juncea, and Curcuma longa L. were determined by high-
performance liquid chromatographywith a diode-array detectormethod.The results revealed rich sources of important compounds
such as robinin in the fruits and leaves of A. aethiopicus; caffeic acid in the tubers of A. aethiopicus and quercitrin in the leaves of
G. pillansii. Further, relatively high antioxidant, antibacterial, and antifungal activities were observed in C. colocynthis fruit coat, S.
alexandrina pods, andA. aethiopicus leaves, respectively.The relatively higher the bioactivities of plants extracts associated with the
phenols in these plants, in particular, themore abundant the phenols.Therefore, it was concluded that the fruit coat ofC. colocynthis,
pods of S. alexandrina, and leaves of A. aethiopicusmight be excellent sources of natural products. These plant extracts also have a
wide spectrum of antimicrobial activities that could be used in the pharmaceutical industries and to control diseases.
1. Introduction
Medicinal plants represent an important part of disease
remedy in economically weak regions of the world, such as
Africa [1, 2]. The South Mediterranean region, including
Egypt, is a rich source of medicinal plants that have several
uses as alternative medicine across history [3, 4]. Some of
these medicinal plants, such as mint [5–7] and basil [8, 9],
have been thoroughly investigated. However, many medici-
nal plants, including Asparagus aethiopicus L. and Citrullus
colocynthis L., have not been well studied, especially their
phenolic profile and bioactivity.
The genus Asparagus, belonging to the family Liliaceae,
contains about 300 species that are widely used as com-
plementary and alternative medicines for treating dysuria,
diabetes, epilepsy, night blindness, tumors, and dysentery.
They are also used for enhancing appetite and increasing
milk secretion in women [10, 11]. The species A. aethiopicus
is common across Egypt, and few studies have investigated
this species. A study on plants of the South Delta region
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indicated that the leaves of A. aethiopicus contain flavonoids
and have moderate antioxidant activities [12]. Furthermore,
other species of Asparagus have revealed great diversity in
their chemical composition. Aberoumand [13] identified fatty
acids in the wild Asparagus officinalis from Iran.
Citrullus colocynthis (L.) Schrad, commonly known as
bitter apple, belongs to the family Cucurbitaceae and grows
naturally in the Egyptian desert. The plant is traditionally
used for treating cancer, leukemia, rheumatism, and amenor-
rhea and also used as an insect repellant [14, 15]. Gurudeeban
et al. [16] reported several traditional uses of the Indian C.
colocynthis, including its use as antidiabetic, antipyretic, anti-
inflammatory, antibacterial, and antifungal agents. However,
the information available on the Egyptian ecotype ofCitrullus
colocynthis is scarce in relation to its phenolic composition
and bioactivities.
Cymbopogon citratus (Poaceae), commonly known as
lemon grass, a native of Southeast Asia, is widely grown in
Africa as a medicinal herb [17].The plant is traditionally used
in folk medicine as an anti-inflammatory agent and also used
as an insect repellent. A recent investigation indicated the
presence of polyphenolic flavonoids, including luteolin and
apigenin, with anti-inflammatory activity in the leaves of C.
citratus [18].
The genus Gasteria, a native of South Africa, contains 23
species. One of the species G. pillansii (L.) Haw, a succulent,
is widely cultivated as an ornamental plant in Egypt [19].
Few studies have been conducted on the genus revealing the
presence of dihydroanthracenones in G. bicolor [20].
Kalanchoe delagoensis L. (Crassulaceae), a succulent
plant, native of Madagascar, is known to contain bufadieno-
lide cardiac glycosides that are toxic [21]. However, thus far,
studies have not been conducted to characterize the phenolic
profile of this plant.
Brassica juncea (Brassicaceae) is traditionally used as a
stimulant, a rubefacient, an emetic, and a diuretic, and it is
consumed as food aswell [22]. Few studies have indicated that
B. juncea contain some phenols [23].
Curcuma longa (Zingiberaceae), commonly known as
turmeric, is considered a medicinal plant and is also used as
a spice. The roots (rhizomes) are used in traditional Indian
andChinesemedicines to treat wounds, acne, flu, and urinary
tract and liver diseases [24]. The roots contain phenols, such
as diferuloylmethane (curcumin), that have antioxidant and
anticancer properties [25, 26].
Another common medicinal plant in Egypt is Senna
alexandrina L. (Fabaceae), which is distributed around the
Nile River. Traditionally, the plant is used for treating stomach
pain and constipation, because of its laxative effects [27, 28].
The pods (fruits) have a high percent of glycosides, including
the sennosides A, B, C, and D, as well as anthraquinones [29,
30]. The phenolic compounds are the major phytochemicals
that are universally present in plants (estimated to be 10,000
compounds) and are responsible for the bioactivity of the
plant extracts [31, 32]. The search for natural products in
plants is strongly associated with the presence of phenolic
compounds, since they have antioxidant and antimicrobial
activities [33–35].The phenolic profile and bioactivities of the
traditional medicinal plants in northern Egypt have not been
fully explored. In the present study, we aimed to investigate
the phenolic qualitative and quantitative profiles of the
selected medicinal plants that are used in complementary
and alternative medicines by the local people. Furthermore,
the antioxidant activity of the extracts was evaluated by 2,2󸀠-
diphenylpicrylhydrazyl (DPPH) and 𝛽-carotene-linoleic acid
assays.The antibacterial and antifungal activities of each plant
were also evaluated to identify and elucidate the bioactivity of
the identified main phenolic compounds.
2. Material and Methods
2.1. Plant Material. The leaves, fruits, and tubers of A.
aethiopicus L. (A. sprengeri Regel) and leaves of both G.
pillansii L. Haw and K. delagoensis L. were obtained from the
Department of Floriculture and Ornamental Horticulture
Nursery in El-Shatby, Alexandria. The fruit coat and flesh
with seeds ofC. colocynthisL., leaves ofC. citratus (DC). Stapf,
and pods of S. alexandrina Mill were obtained from com-
mercial farms in Alexandria Governorate in northern Egypt.
Further, the seeds of B. juncea L. and roots of C. longa L.
were procured from a local herbalist. All the plants were
identified by Dr. H. Elansary and vouchered at the Faculty
of Agriculture, Alexandria, in June 2017.
2.2. Bioactivity Assays. To determine the bioactivity of the
samples, the total dry weight was determined by drying the
cleaned plant parts (0.25mg) in an oven at 35∘C to reach a
constant weight and then weighed. The samples were then
ground and dissolved in 3mLmethanol (99%) in dark condi-
tion, for 1 h, at room temperature. The extracts were cen-
trifuged at 10,000 rpm (7000×g) for 5min and the super-
natant (∼2.7mL) was stored at −80∘C. All the chemicals
used were of analytical/HPLC grade bought from Sigma-
Aldrich (Cairo, Egypt). The fungal and bacterial strains were
procured from the Departments of Plant Pathology and
Floriculture and Ornamental Horticulture, Faculty of Agri-
culture, Alexandria, Egypt.
2.3. HPLC-DAD Analyses. The plant materials that were
dried by lyophilization (Labconco, USA) were powdered
using amortar.The plant samples of 0.2 g each were extracted
following the procedure described by Szopa et al. [36].
The methanolic extracts were subjected to chromatographic
analyses by a modified validated HPLC method [37–39].
Quantification was carried out by comparing the UV-DAD
spectra and 𝑡
𝑟
values with that of the commercially available
standards of the following groups of metabolites: free phe-
nolic acids (3,4-dihydroxyphenylacetic, caffeic, chlorogenic,
o-coumaric,m-coumaric, p-coumaric, ferulic, gallic, gentisic,
hydrocaffeic, p-hydroxybenzoic, isoferulic, neochlorogenic,
protocatechuic, rosmarinic, salicylic, sinapic, syringic, and
vanillic acids; and precursors of phenolic acids: cinnamic and
benzoic acids), flavonoids (aglycones: kaempferol, luteolin,
myricetin, quercetin, and rhamnetin; glycosides: apigetrin,
cynaroside, hyperoside, isoquercetin, quercitrin, robinin,
rutin, trifolin, and vitexin), coumarins (bergapten, esculin,
6-hydroxy-4-methylcoumarin, imperatorin, isopimpinellin,
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marmesin, psoralen, umbelliferone, and xanthotoxin), cate-
chins (epicatechin, epicatechin gallate, epigallocatechin, and
epigallocatechin gallate), and phenolic compound biosyn-
thetic precursors (phenylalanine and tyrosine) (the com-
pounds were supplied by Sigma-Aldrich, Germany). An
HPLC-DAD (Merck-Hitachi) and a Purospher RP-18e ana-
lytical column (4 × 250mm, 5mL; Merck) were used for
the analyses. The gradient program used included the flow
rate of 1mL/min, injection volume of 10 𝜇L, and detection
wavelength of 254 nm [36, 40, 41]. The representative chro-
matograms have been provided as Supplementary Figures 1
and 2.
2.4. Antioxidant Activity. The antioxidant activities of all the
samples were determined by DPPH and 𝛽-carotene-linoleic
acid assays [9]. In the DPPH method, the absorbance was
measured at 517 nm, following 30min of treatment. In the 𝛽-
carotene-linoleic acid assay, the absorbance was measured at
470 nm.The sample concentration required to scavenge 50%
of the DPPH/𝛽-carotene-linoleic acid (IC
50
in 𝜇g/mL) was
determined by plotting the inhibition percent against extract
concentration. Butylated hydroxytoluene (BHT) was used as
a positive control.The antioxidant activity of each sample was
compared with that of the BHT and blank. Experiments were
repeated twice in triplicate.
2.5. Antibacterial Activity. The antibacterial activity of plant
extracts was screened against Gram-positive and Gram-
negative bacteria, including Listeria monocytogenes (clini-
cal isolate), Staphylococcus aureus (ATCC 6538), Bacillus
cereus (ATCC 14579), Micrococcus flavus (ATCC 10240).
Pseudomonas aeruginosa (ATCC 27853), and Escherichia coli
(ATCC 35210). The microdilution method was used to deter-
mine theminimum inhibitory concentration (MIC) andmin-
imum bactericidal concentration (MBC) of the plant extracts
[42]. The 96-well microtiter plates were used, and each well
of the plate contained known concentration of plant extracts
+ 100 𝜇L tryptic soy broth containing bacterial inoculum (1.0
× 104 CFU per well). These plates were incubated at 37∘C for
24 h in a rotary shaker and the MICs and MBCs were deter-
mined after the incubation period. The lowest concentration
of plant extract that exhibited no visible growth (observed
under a binocular microscope) was defined as the MIC. The
MBC was determined using serial subculturing of the 2 𝜇L
plant extracts into microtiter plates containing 100𝜇L of TSB
in each well. The microtiter plates were incubated at 37∘C
for 24 h. The MBC was defined as the lowest concentration
that caused no visible growth which indicated killing of
99.5% of the inoculum. The optical density was determined
at 655 nm and all the experiments were performed twice
in triplicate. Positive (streptomycin, 0.01–10mg/mL) and
negative (DMSO, 5%) controls were also used.
2.6. Antifungal Activity. Several fungi, including Aspergillus
flavus (ATCC 9643), A. ochraceus (ATCC 12066), A. niger
(ATCC 6275), Penicillium ochrochloron (ATCC 48663), P.
funiculosum (ATCC 56755), and Candida albicans (ATCC
12066), were used to test the antifungal activity of leaf extracts
using the microdilution method [42]. Known concentrations
of each leaf extract (2 𝜇L) were added to microtiter plates
(with a capacity of 96 wells) with each well containing
broth Malt medium mixed with each fugal inoculum (spore
suspension concentration of 1.0 × 105). The microtiter plates
were incubated at 28∘C for 72 h in a rotary shaker. The
minimum inhibitory concentrations (MICs) were calculated
as the lowest concentration that inhibited fungal growth at
the binocular microscopic level. The minimum fungicidal
concentrations (MFCs) were calculated using a serial sub-
cultivations of the leaf extracts (2 𝜇L) added to microtiter
plates that contained 100 𝜇L of broth and inoculums and
then incubated at 28∘C for 72 h. The MFC was defined as the
minimum concentration that caused no visible growth which
indicated the killing of 99.5% of the original inoculum. The
ketoconazole (KTZ) (1–3500 𝜇g/mL) was used as a positive
control. All experiments were repeated twice in triplicate.
2.7. Statistical Analyses. Statistical analysis was performed
using SPSS version 22.0, and the results were analyzed by least
significance difference (LSD) in the ANOVA.
3. Results
3.1. Targeted Profiling of Biologically Active Metabolites
3.1.1. Asparagus aethiopicus. The HPLC-DAD analysis of
fruit, leaf, and tuber extracts ofA. aethiopicus revealed the dif-
ferences in the chemical composition between them (Table 1).
In the fruit extracts, three phenolic acids, chlorogenic, gal-
lic, and syringic acids, and four flavonoids, isoquercetin,
quercetin, quercitrin, and robinin, were confirmed. The
predominant phenolic acid was gallic acid (12.20mg per
100 g DW), while robinin (kaempferol 3-O-robinoside-7-
O-rhamnoside) (40.01mg per 100 g DW) and quercitrin
(quercetin 3-rhamnoside) (37.08mg per 100 g DW) were the
predominant flavonoids.
In the leaf extracts, four phenolic acids were detected,
including caffeic, chlorogenic, gallic, and vanillic acids, with
chlorogenic acid (31.72mg per 100 g DW) being the most
abundant. In the leaf extract relatively high amounts of
robinin (1356.90mg per 100 gDW), rutin (176.33mg per 100 g
DW), and apigenin (59.59mg per 100 g DW)were confirmed,
as well.
The phenolic profile of tuber extract was relatively poor
and revealed four phenolic acids, of which three were similar
to those of the leaf extracts (caffeic, chlorogenic, and gallic
acids), in addition to protocatechuic acid. Relatively high
amounts of caffeic acid (62.18mg per 100 g DW) and gallic
acid (20.33mg per 100 g DW) were observed.
3.1.2. Citrullus colocynthis. The extracts ofC. colocynthis fruit
parts (fruit coat, fruit flesh, and seeds) exhibited similarity
in their phenolic profiles (Table 2). Five similar phenolic
acids were quantified, including caffeic, p-coumaric, ferulic,
p-hydroxybenzoic, and hydroxycaffeic acids.Thehydroxycaf-
feic acid was the predominant compound (277.45, 117.46, and
97.25mg per 100 g DW in the fruit coat, fruit flesh, and seed
extracts, resp.). Further, the fruit coat and seed extracts con-
tained relatively high amounts of 3,4-dihydroxyphenylacetic
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Table 1: Chemical composition of Asparagus aethiopicus and Citrullus colocynthis economic plant parts.
Plant part Chemical compound Amount [mg 100 g−1] D.W.
Asparagus aethiopicus (Fruit)
Chlorogenic acid 5.21 ± 0.36
Gallic acid 12.20 ± 0.06
Syringic acid 2.68 ± 0.92
Quercetin 12.61 ± 0.00
Quercitrin 37.08 ± 0.04
Isoquercetin 7.44 ± 0.04
Robinin 40.01 ± 0.06
A. aethiopicus (tubers)
Chlorogenic acid 3.17 ± 0.76
Gallic acid 20.33 ± 0.15
Caffeic acid 62.18 ± 1.03
Protocatechuic acid 8.01 ± 0.01
A. aethiopicus (leaves)
Chlorogenic acid 31.72 ± 4.24
Gallic acid 10.39 ± 2.17
Caffeic acid 11.15 ± 2.97
Vanillic acid 5.98 ± 0.66
Robinin 1356.90 ± 2.18
Apigenin 59.59 ± 6.11
Rutin 176.33 ± 0.47
Citrullus colocynthis (fruit coat)
Ferulic acid 2.02 ± 0.09
3,4-Dihydroxyphenylacetic acid 221.46 ± 3.13
p-Hydroxybenzoic acid 2.26 ± 0.16
Hydroxycaffeic acid 277.45 ± 15.66
Caffeic acid 4.31 ± 0.95
p-Coumaric acid 2.80 ± 0.01
6-Hydroxy-4-methylcoumarin 58.86 ± 0.23
Syringic acid 0.22 ± 0.01
Phenylalanine 747.83 ± 4.99
C. colocynthis (fruit flesh)
Ferulic acid 3.61 ± 0.06
p-Hydroxybenzoic acid 5.51 ± 0.24
Hydroxycaffeic acid 117.46 ± 17.16
Caffeic acid 13.36 ± 2.88
p-Coumaric acid 14.47 ± 2.39
C. colocynthis (Seeds)
Ferulic acid 5.76 ± 0.68
3,4-Dihydroxyphenylacetic acid 47.08 ± 0.10
p-Hydroxybenzoic acid 12.68 ± 0.24
Hydroxycaffeic acid 97.25 ± 0.93
Caffeic acid 4.18 ± 0.09
p-Coumaric acid 2.83 ± 0.30
Protocatechuic acid 2.25 ± 0.01
Syringic acid 0.43 ± 0.05
Phenylalanine 120.78 ± 1.47
acid (221.46 and 47.08mg per 100 g DW, resp.) and trace
amounts of syringic acid (0.22 and 0.43mg per 100 g DW).
In addition to these, the biosynthetic precursor of phenolic
compounds, phenylalanine (747.83 and 120.78mg per 100 g
DW, resp., in the fruit coat and seed extracts) was detected
in considerable amount.
3.1.3. Cymbopogon citratus, Gasteria pillansii, and Kalanchoe
delagoensis. Thephenolic profiles of the economically impor-
tant part (leaves) of C. citratus, G. pillansii and K. delagoensis
were determined (Table 3). The leaf extract of C. citratus
revealed seven phenolic compounds, including one flavonoid
(rutin, 155.52mg per 100 g DW). The amounts of phenolic
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Table 2: Chemical composition of Senna alexandrina, Brassica juncea, and Curcuma longa economic plant parts.
Plant part Chemical compound Amount [mg 100 g−1] D.W.
Senna alexandrina (pods or fruits)
Gallic acid 15.94 ± 0.64
Gentisic acid 363.21 ± 18.64
Caffeic acid 13.34 ± 0.51
Neochlorogenic acid 65.15 ± 3.72
Protocatechuic acid 31.52 ± 1.86
Syringic acid 5.88 ± 0.23
Vanillic acid 5.06 ± 0.09
Epigallocatechin 187.50 ± 0.20
Benzoic acid 369.15 ± 15.89
6-Hydroxy-4-methylcoumarin 62.72 ± 3.70
Cynaroside 73.28 ± 2.82
Kaempferol 137.74 ± 0.52
Quercetin 80.06 ± 3.20
Isoquercetin 195.15 ± 7.41
Luteolin 22.81 ± 1.34
Rhamnetin 291.30 ± 8.73
Psoralene 20.93 ± 0.27
Isorhamnetin 51.31 ± 0.99
Brassica juncea (seeds)
Chlorogenic acid 45.03 ± 4.53
Gallic acid 9.14 ± 0.06
Ferulic acid 9.49 ± 0.11
Caffeic acid 5.21 ± 0.31
Neochlorogenic acid 18.60 ± 0.02
Syringic acid 2.04 ± 0.22
Vanillic acid 4.46 ± 0.08
Esculin 294.90 ± 0.63
Umbelliferone 277.27 ± 9.69
Sinapic acid 5.13 ± 4.32
Epigallocatechin 45.12 ± 0.03
Curcuma longa L. (roots)
Ferulic acid 15.04 ± 1.49
3,4-Dihydroxyphenylacetic acid 33.26 ± 0.51
p-Hydroxybenzoic acid 2.77 ± 0.39
Hydroxycaffeic acid 64.40 ± 1.60
p-Coumaric acid 8.11 ± 2.62
Protocatechuic acid 2.93 ± 0.03
Syringic acid 2.22 ± 0.01
acids were relatively high, with chlorogenic (49.98mg per
100 g DW) and 3,4-dihydroxyphenylacetic acid (60.21mg per
100 g DW) being the predominant ones. The biosynthetic
precursor of phenolic acids (cinnamic acid, 50.44mg per
100 g DW) was also found in relatively high amounts.
The phenolic profile of G. pillansii leaf extracts contained
several phenolic acids such as p-coumaric (14.11mg per 100 g
DW), ferulic (67.62mg per 100 g DW), and gallic (15.04mg
per 100 g DW) acids, including their biosynthetic precursor,
cinnamic acid (4.80mg per 100 g DW). In the leaf extracts of
G. pillansii, relatively high amounts of quercitrin (83.08mg
per 100 g DW) and quercetin (65.81mg per 100 g DW) were
confirmed, in addition to the other flavonoids, isoquercetin,
and rutin.
The leaf extracts of K. delagoensis contained relatively
high amounts of phenolic acids and flavonoids. Five phenolic
acids were detected in significant amounts, including gallic
acid (152.21mg per 100 g DW) and caffeic acid (65.28mg
per 100 g DW). High amounts of the flavonoids such
as trifolin (kaempferol 3-galactoside) (873.63mg per 100 g
DW), kaempferol (207.41mg per 100 g DW), isoquercetin
(120.58mg per 100 g DW), and quercitrin (89.86mg per 100 g
DW) were detected.
3.1.4. Brassica juncea. The seed extracts of B. juncea revealed
the presence of phenolic acids, coumarins, and epigallocat-
echin (Table 4). The predominant phenolic acids included
chlorogenic acid (45.03mg per 100 g DW) and its isomer,
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Table 3: Chemical composition of Cymbopogon citratus, Gasteria pillansii, and Kalanchoe delagoensis economic plant parts.
Plant part Chemical compound Amount [mg 100 g−1] D.W.
Cymbopogon citratus (leaves)
Chlorogenic acid 49.98 ± 0.62
Cinnamic acid 50.44 ± 0.03
3,4-Dihydroxyphenylacetic acid 60.21 ± 0.60
Caffeic acid 8.74 ± 0.02
Protocatechuic acid 4.36 ± 0.02
Vanillic acid 2.95 ± 0.03
Rutin 155.52 ± 0.32
Gasteria pillansii/G. maculata (leaves)
Cinnamic acid 4.80 ± 1.23
Ferulic acid 67.62 ± 2.25
Gallic acid 15.04 ± 0.01
Ferulic acid 27.15 ± 0.05
p-Coumaric acid 14.11 ± 5.54
Quercetin 65.81 ± 4.50
Isoquercetin 8.04 ± 0.89
Quercitrin 83.08 ± 11.05
Rutin 41.83 ± 5.04
Kalanchoe delagoensis L. or Bryophyllum delagoense L. (leaves)
Ferulic acid 25.92 ± 0.12
Gallic acid 152.21 ± 0.45
Caffeic acid 65.28 ± 0.71
Protocatechuic acid 32.38 ± 0.11
Syringic acid 11.90 ± 0.62
Trifoline 873.63 ± 2.82
Kaempferol-7 o-rhamnoside 47.65 ± 0.42
Kaempferol 207.41 ± 0.94
Quercetin 89.86 ± 1.49
Isoquercetin 120.58 ± 1.01
Robinin 125.69 ± 1.98
Quercitrin 155.65 ± 0.88
Table 4: DPPH and 𝛽-carotene-linoleic acid assay of A. aethiopicus, C. colocynthis, S. alexandrina, B. juncea, C. longa, C. citratus, G. pillansii,
and K. delagoensismethanolic extracts. Values are expressed as mean of triplicate determinations ± sd.
DPPH free radical
scavenging activity
(IC
50
, 𝜇g mL−1)
𝛽-Carotene-
linoleic acid assay
(IC
50
, 𝜇g mL−1)
Asparagus aethiopicus (leaves) 3.1 ± 0.1 2.7 ± 0.1
Asparagus aethiopicus (fruit) 8.4 ± 0.1 9.9 ± 0.1
Asparagus aethiopicus (tubers) 8.1 ± 0.1 9.5 ± 0.1
Citrullus colocynthis (fruit coat) 2.4 ± 0.1 2.3 ± 0.1
Citrullus colocynthis (fruit flesh) 6.5 ± 0.2 7.8 ± 0.3
Citrullus colocynthis seeds 7.8 ± 0.1 8.9 ± 0.3
Senna alexandrina (pods or fruit) 2.6 ± 0.1 2.4 ± 0.1
Brassica juncea (seeds) 5.4 ± 0.1 6.2 ± 0.1
Curcuma longa L. (roots) 7.3 ± 0.3 8.2 ± 0.1
Cymbopogon citratus (leaves) 8.3 ± 0.3 9.4 ± 0.3
Gasteria pillansii (leaves) 5.4 ± 0.1 6.5 ± 0.1
Kalanchoe delagoense L. (leaves) 4.1 ± 0.1 4.9 ± 0.1
BHT 2.9 ± 0.2 2.6 ± 0.1
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neochlorogenic acid (18.60mg per 100 g DW). Other pheno-
lic acids (caffeic, ferulic, gallic, sinapic, syringic, and vanillic
acids) were also quantified; however, they were in relatively
low amounts (<10mg per 100 g DW). In the seed extracts,
two coumarins, esculin (294.90mg per 100 g DW) and
umbelliferone (277.27mg per 100 g DW), were confirmed.
3.1.5. Curcuma longa. Thechromatographic analysis of theC.
longa root extracts revealed the presence of seven phenolic
aids, including p-coumaric, 3,4-dihydroxyphenylacetic, fer-
ulic, p-hydroxybenzoic, hydroxycaffeic, protocatechuic, and
syringic acids. The predominant compounds were hydrox-
ycaffeic acid (64.40mg per 100 g DW), 3,4-dihydroxy-
phenylacetic acid (33.26mg per 100 g DW), and ferulic acid
(15.04mg per 100 g DW).
3.1.6. Senna alexandrina. The pod extract of S. alexandrina
contained three groups of secondary metabolites, including
phenolic acids, flavonoids, and coumarins (Table 6). The
precursor of the phenolic acids, benzoic acid, was quantified
in relatively high amount (369.15mg per 100 g DW). Also,
seven phenolic acids (caffeic, gallic, gentisic, neochlorogenic,
protocatechuic, syringic, and vanillic acids) were detected.
High amounts of gentisic acid (363.21mg per 100 g DW),
neochlorogenic acid (65.15mg per 100 g DW), and protocat-
echuic acid (31.52mg 100 g DW) were detected.
Furthermore, seven flavonoids (cynaroside, isoquercetin,
isorhamnetin, kaempferol, luteolin, quercetin, and rham-
netin) were detected in relatively high amounts ranging
from 22.81 to 291.30mg per 100 g DW. The predominant
compounds were rhamnetin (291.30mg per 100 g DW),
isoquercetin (195.15mg per 100 g DW), and kaempferol
(137.74mg per 100 g DW). In the S. alexandrina pod extracts,
two coumarins, 6-hydroxy-4-methylcoumarin (62.72mg per
100 g DW) and psoralene (20.93mg per 100 g DW), were also
detected.
3.2. Antioxidant Activities. Methanolic extracts of the leaves
were subjected to DPPH and 𝛽-carotene-linoleic acid assays,
and the results are presented in Table 4. The antioxidant
activities expressed as IC
50
ranged from 2.4 to 8.4 𝜇g/mL and
2.3 to 9.9 𝜇g/mL in the DPPH and 𝛽-carotene-linoleic acid
assays, respectively.
Relatively high antioxidant activities (low IC
50
, 𝜇g/mL)
was exhibited by C. colocynthis fruit coat (DPPH = 2.4; 𝛽-
carotene = 2.3), S. alexandrina pods (DPPH = 2.6; 𝛽-carotene
= 2.4), and A. aethiopicus leaves (DPPH = 3.1; 𝛽-carotene =
2.7). They showed higher antioxidant activities than that of
the BHT standard. Other plant samples of K. delagoensis, G.
pillansii, and B. juncea revealed moderate antioxidant activ-
ities. Relatively low antioxidant activities were observed in
A. aethiopicus fruits and tubers, C. colocynthis fruit flesh and
seeds, C. longa roots, and C. citratus leaves. Both the assays
followed a similar pattern in their values for the antioxi-
dant activities.
3.3. Antibacterial Activities. The plant parts showed great
variation in the antibacterial activities, expressed as MIC and
MBC, of their methanolic extracts (Table 5). The MIC and
MBC ranged from0.02 to 0.43mg/mL and 0.4 to 0.73mg/mL,
respectively. The pods of S. alexandrina, C. colocynthis
fruit coat, and A. aethiopicus leaves revealed relatively high
antibacterial activities, with relatively low MIC and MBC
compared to streptomycin. The fruit flesh and seeds of C.
colocynthis showed moderate to high antibacterial activities
against bacteria, such as P. aeruginosa, E. coli, M. flavus, and
S. aureus.The seeds of B. juncea and roots ofC. longa revealed
high tomoderate antibacterial activities when comparedwith
other plants. The tubers of A. aethiopicus exhibited relatively
low antibacterial activity against most organisms.
3.4. Antifungal Activities. The antifungal activities of meth-
anolic extracts were expressed as MIC and MFC (Table 6).
The MIC and MFC values ranged from 0.08 to 0.33mg/mL
and 0.16 to 0.75mg/mL, respectively.The fruit coat of C. colo-
cynthis, pods of S. alexandrina, and leaves of A. aethiopicus
showed relatively high antifungal activities in general with
lowMIC andMBC values compared to the standard reagent.
The other plant extracts, such as C. colocynthis fruit flesh and
seeds, B. juncea seeds, and C. longa roots, exhibited moderate
antifungal activities.
4. Discussion
The extracts of A. aethiopicus (leaves, fruits, and tubers), G.
pillansii (leaves), S. alexandrina (pods), C. colocynthis (fruit
coat and flesh and seeds), K. delagoensis (leaves), C. citratus
(leaves), B. juncea (seeds), and C. longa (roots) revealed
significant variations in their phenol profile (Tables 1–6).
The major compound found in the leaves of A. aethiopi-
cus was the glucoside flavonoid, robinin (1356.90mg per
100 g DW). Its concentration was significantly higher than
that of all other compounds detected in the investigated
samples. The sources of robinin, in nature, are limited; few
investigations have detected this flavonoid in some plants,
such as Pueraria lobata [43]. However, the present study
revealed a rich and new source of robinin, the leaves of A.
aethiopicus. Previous investigations on A. aethiopicus have
isolated other flavonoids, including apigenin, apigenin-7-
O-glucoside, dihydroquercetin, and naringenin, and they
also reported moderate antioxidant activity of the alcoholic
extract [12]. However, in the present study, 12 phenolic
compounds were isolated from the leaves, fruits, and tubers,
in addition to apigenin in relatively low amount in the leaves.
In C. colocynthis, the fruit coat had higher phenylalanine
content when compared with other extracts, including the
seed and fruit flesh of colocynthis. A previous study has
reported the presence of phenylalanine in the seeds of the
Indian C. colocynthis [16]. However, the present study was
the first to report six times higher phenylalanine content
in the fruit coat of C. colocynthis than that of the seeds
in the Egyptian ecotype. Further, the fruit coat contained
other major compounds, such as 3,4-dihydroxyphenylacetic
acid and hydroxycaffeic acid. The pods of S. alexandrina
contained high amounts of gentisic acid, benzoic acid, rham-
netin, isoquercetin, and kaempferol, and the presence of
these compounds have not been reported. However, Franz
[27] reported the presence of other glycosides, belonging to
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the anthraquinone family, in S. alexandrina. In the present
study, B. juncea seeds contained high amounts of esculin,
umbelliferone, epigallocatechin, and chlorogenic acid. A
previous study conducted on the extracts of Indian B. juncea
confirmed the presence of sinigrin, quercetin, vanillin, and
catechin [23].
The presence of phenolic compounds, such as hydroxy-
caffeic acid in C. longa roots; rutin, 3,4-dihydroxyphenyl-
acetic acid, chlorogenic acid, and cinnamic acid in C. cit-
ratus; quercitrin, ferulic acid, and quercetin in G. pillansii;
trifoline, kaempferol, quercitrin, gallic acid, and isoquercetin
in K. delagoensis have not been reported before this study.
However, a study on C. citratus reported the presence of spe-
cific flavonoids with anti-inflammatory activity, such as car-
linoside, isoorientin, cynaroside, and luteolin [18]. Further-
more, 3,4-dihydroxyphenylacetic acid is considered as a
metabolite of curcumin and has been reported in C. longa
[26].
High antioxidant activity is usually associated with the
phenols in the plants, especially the more abundant phenols
[9, 44, 45]. Phenols are the secondary metabolites of plants
with obvious antioxidant activities. Flavonoids, a class of
phenols, such as kaempferol, tripholine, astragalin, robinin,
and quercetin, have strong antioxidants that limit free rad-
ical accumulation and scavenge free radicals [46]. In the
present study, relatively high antioxidant activitieswere found
in C. colocynthis fruit coat, S. alexandrina pods, and A.
aethiopicus, and the major compounds detected in these
plant extracts were phenylalanine, benzoic acid, and robinin,
respectively. Recent studies indicated that phenylalanine and
benzoic acid might be strong antioxidants [47, 48]. Further,
the fruit coat of C. colocynthis, with relatively high 3,4-
dihydroxyphenylacetic content in the present study, has been
associated with strong antioxidant activity [49]. Lau et al.
[43] reported high antioxidant activity of Pueraria lobata
containing high amounts of robinin, which is analogous
to the findings of the present study. The high antioxidant
activity exhibited by A. aethiopicusmight be attributed to the
high robinin content. The leaves of A. aethiopicus contained
other phenolic compounds, such as rutin and chlorogenic
acid, and these compounds have been known to have strong
antioxidant activities [50].
Previous investigations [51, 52] have indicated that the
phenols and flavonoids present in the plants may have an
influence on the microorganism growth. Generalić et al. [51]
reported that leaf extracts of Salvia officinalis L. contained
high amounts of phenols and flavonoids exhibiting high
antibacterial activity, especially against E. coli, S. aureus, and
B. cereus. In the present study, relatively high antibacterial
activities were discovered in the extracts of S. alexandrina
pods, C. colocynthis fruit coat, and A. aethiopicus leaves.
The phenylalanine in the C. colocynthis fruit coat has been
reported to have antibacterial activity [53]. Ali et al. [54]
reported that the Weinreb amides 3, 4, and 5 of alanine
and phenylalanine exhibited good activity against E. coli
and Pseudomonas aeruginosa; however, poor results were
observed against S. aureus and B. subtilis. Further, Gurudee-
ban et al. [16] reported high antibacterial activity of the
methanolic extracts of C. colocynthis fruits against bacteria,
such as B. subtilis, Streptococcus pyogenes, and Salmonella
typhi. Robinin extracted from Robinia pseudoacacia L. has
high antibacterial activity [55, 56]. Benzoic acid and its
derivatives have antibacterial activities and might be used
as food preservatives [57]. In the present study, the fruit
coat of C. colocynthis, pods of S. alexandrina, and leaves of
A. aethiopicus showed relatively high antifungal activities in
general, whichmight be attributed to high amounts of specific
phenols in these plants. This is in agreement with the results
of previous investigations [58, 59]. Zhang et al. [60] reported
high antifungal activities of Robinia pseudoacacia extracts,
and this was attributed to high robinin content. Further,
Al-Snafi [61] emphasized the antibacterial and antifungal
activities of the seeds of C. colocynthis. However, the present
study was the first to explore the profile of these important
phenols in C. colocynthis fruit parts. Further, Gurudeeban et
al. [16] reported strong antifungal activities of C. colocynthis
against Aspergillus fumigatus andMucor sp.
5. Conclusions
The plants studied revealed great diversity in their phenolic
profile and also their antioxidant, antibacterial, and antifun-
gal activities.Themajor phenols identifiedwere robinin in the
leaves and fruits of A. aethiopicus, caffeic acid in A. aethiopi-
cus (tubers), quercitrin inG. pillansii (leaves), benzoic acid in
S. alexandrina (pods), phenylalanine in C. colocynthis (fruit
coat and seeds), hydroxycaffeic acid in C. colocynthis (fruit
flesh), trifoline in K. delagoensis (leaves), rutin in C. citratus
(leaves), esculin in B. juncea (seeds), and hydroxycaffeic acid
in C. longa (roots). The leaves of A. aethiopicus had relatively
high amount of the phenolic compound, robinin compared
with the other plants studied. Relatively high antioxidant,
antibacterial, and antifungal activities were observed in C.
colocynthis fruit coat, S. alexandrina pods, andA. aethiopicus.
The high bioactivity of plant extracts was associated with the
presence of phenols, especially the more abundant phenols:
phenylalanine, benzoic acid, and robinin, respectively. Fur-
ther, it could be concluded that the fruit coat ofC. colocynthis,
pods of S. alexandrina, and parts of A. aethiopicus might be
excellent sources of natural products that could be used in the
pharmaceutical industries and control of diseases.
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